Schnitzler M |
Diabetes mellitus after kidney transplantation in the United States. |
2003 |
Am. J. Transplant. |
pmid:14510709
|
Spada M et al. |
Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. |
2006 |
Am. J. Transplant. |
pmid:16771811
|
Donners MM et al. |
Low-dose FK506 blocks collar-induced atherosclerotic plaque development and stabilizes plaques in ApoE-/- mice. |
2005 |
Am. J. Transplant. |
pmid:15888024
|
Woodward RS et al. |
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. |
2003 |
Am. J. Transplant. |
pmid:12752315
|
Lehmann R et al. |
Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up. |
2004 |
Am. J. Transplant. |
pmid:15196070
|
Lemahieu W et al. |
Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea. |
2005 |
Am. J. Transplant. |
pmid:15888045
|
Axelrod D et al. |
Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15888050
|
Reyes J et al. |
Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). |
2005 |
Am. J. Transplant. |
pmid:15888051
|
Kim EJ et al. |
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. |
2014 |
Am. J. Transplant. |
pmid:24354871
|
Frassetto LA et al. |
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17949460
|
Campbell PM et al. |
Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. |
2007 |
Am. J. Transplant. |
pmid:17456201
|
Singh K et al. |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. |
2014 |
Am. J. Transplant. |
pmid:25359003
|
Dugast E et al. |
Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27367750
|
Tang Q |
Pharmacokinetics of therapeutic Tregs. |
2014 |
Am. J. Transplant. |
pmid:25358900
|
Wen X et al. |
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27137884
|
Trofe-Clark J et al. |
Immunosuppression, generic drugs and the FDA. |
2012 |
Am. J. Transplant. |
pmid:22176626
|
Sikma MA et al. |
Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. |
2015 |
Am. J. Transplant. |
pmid:26053114
|
English RF et al. |
Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12243498
|
de Fontbrune FS et al. |
Veno-occlusive disease of the liver after lung transplantation. |
2007 |
Am. J. Transplant. |
pmid:17697264
|
Kurtz J et al. |
Lack of role for CsA-sensitive or Fas pathways in the tolerization of CD4 T cells via BMT and anti-CD40L. |
2003 |
Am. J. Transplant. |
pmid:12814472
|
Gupta G et al. |
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. |
2015 |
Am. J. Transplant. |
pmid:25988397
|
Ekberg H et al. |
Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. |
2009 |
Am. J. Transplant. |
pmid:19563339
|
Mehra MR et al. |
Immunosuppression in cardiac transplantation: science, common sense and the heart of the matter. |
2006 |
Am. J. Transplant. |
pmid:16686745
|
Grimm M et al. |
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial. |
2006 |
Am. J. Transplant. |
pmid:16686762
|
Sis B et al. |
Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. |
2006 |
Am. J. Transplant. |
pmid:16686769
|
Damon C et al. |
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening. |
2017 |
Am. J. Transplant. |
pmid:27597269
|
Shuker N et al. |
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation. |
2016 |
Am. J. Transplant. |
pmid:26714287
|
Bouamar R et al. |
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). |
2013 |
Am. J. Transplant. |
pmid:23480233
|
Busque S et al. |
The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation. |
2011 |
Am. J. Transplant. |
pmid:21943027
|
Kaufman DB et al. |
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results. |
2005 |
Am. J. Transplant. |
pmid:16162205
|
Mujtaba MA et al. |
Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients. |
2014 |
Am. J. Transplant. |
pmid:25179306
|
Schwarz A et al. |
Polyoma virus nephropathy in native kidneys after lung transplantation. |
2005 |
Am. J. Transplant. |
pmid:16162212
|
Flechner SM et al. |
Allotransplantation of cryopreserved parathyroid tissue for severe hypocalcemia in a renal transplant recipient. |
2010 |
Am. J. Transplant. |
pmid:20883540
|
BenÃtez CE et al. |
ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20883560
|
Böger CA et al. |
Reverse diastolic intrarenal flow due to calcineurin inhibitor (CNI) toxicity. |
2006 |
Am. J. Transplant. |
pmid:16889550
|
Shemesh E et al. |
The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study. |
2017 |
Am. J. Transplant. |
pmid:28321975
|
Tan HP et al. |
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. |
2006 |
Am. J. Transplant. |
pmid:16889606
|
Hirsch HH et al. |
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12. |
2016 |
Am. J. Transplant. |
pmid:26639422
|
Pescovitz MD et al. |
A randomized, double-blind, pharmacokinetic study of oral maribavir with tacrolimus in stable renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19663892
|
Bohl DL et al. |
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. |
2005 |
Am. J. Transplant. |
pmid:16095500
|
Kasahara M et al. |
Living-donor liver transplantation for hepatoblastoma. |
2005 |
Am. J. Transplant. |
pmid:16095502
|
Lemahieu WP et al. |
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. |
2005 |
Am. J. Transplant. |
pmid:16095503
|
Meier-Kriesche HU et al. |
Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. |
2005 |
Am. J. Transplant. |
pmid:16095509
|
Senior PA et al. |
Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. |
2005 |
Am. J. Transplant. |
pmid:16095517
|
Gao R et al. |
Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells. |
2007 |
Am. J. Transplant. |
pmid:17391142
|
Meier-Kriesche HU and Kaplan B |
Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with sandimmune. |
2002 |
Am. J. Transplant. |
pmid:12095048
|
Rodriguez-Rodriguez AE et al. |
The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats. |
2013 |
Am. J. Transplant. |
pmid:23651473
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Padiyar A et al. |
Clinical predictors of proteinuria after conversion to sirolimus in kidney transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20055793
|
Hardinger KL et al. |
BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. |
2010 |
Am. J. Transplant. |
pmid:20055811
|
Neuberger JM et al. |
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. |
2009 |
Am. J. Transplant. |
pmid:19120077
|
Tan HP et al. |
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. |
2009 |
Am. J. Transplant. |
pmid:19120078
|
Ashman N et al. |
Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy. |
2009 |
Am. J. Transplant. |
pmid:19120084
|
Vongwiwatana A et al. |
Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. |
2004 |
Am. J. Transplant. |
pmid:14678043
|
Bressollette-Bodin C et al. |
A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996241
|
Augustine JJ et al. |
Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996247
|
Filler G et al. |
Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure. |
2005 |
Am. J. Transplant. |
pmid:15996252
|
Fan DM et al. |
Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up. |
2015 |
Am. J. Transplant. |
pmid:25808777
|
Awadalla Y et al. |
HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. |
2004 |
Am. J. Transplant. |
pmid:15367226
|
Froud T et al. |
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. |
2005 |
Am. J. Transplant. |
pmid:15996257
|
Borrows R et al. |
Mycophenolic acid 12-h trough level monitoring in renal transplantation: association with acute rejection and toxicity. |
2006 |
Am. J. Transplant. |
pmid:16433766
|
Kohnle M et al. |
Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16433776
|
Luther P and Baldwin D |
Pioglitazone in the management of diabetes mellitus after transplantation. |
2004 |
Am. J. Transplant. |
pmid:15575920
|
Dahm F et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15575921
|
Pascher A et al. |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. |
2015 |
Am. J. Transplant. |
pmid:25677074
|
Okabayashi T et al. |
Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. |
2011 |
Am. J. Transplant. |
pmid:21883903
|
Hellemons ME et al. |
Former smoking is a risk factor for chronic kidney disease after lung transplantation. |
2011 |
Am. J. Transplant. |
pmid:21883906
|
Mulay AV et al. |
Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. |
2009 |
Am. J. Transplant. |
pmid:19353768
|
Bourdeaux C et al. |
Living-related versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients. |
2007 |
Am. J. Transplant. |
pmid:17173657
|
Zheng H et al. |
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. |
2003 |
Am. J. Transplant. |
pmid:12694072
|
Montgomery SP et al. |
Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. |
2002 |
Am. J. Transplant. |
pmid:12118862
|
Ahsan N et al. |
Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation. |
2002 |
Am. J. Transplant. |
pmid:12118902
|
Rostaing L et al. |
Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial. |
2013 |
Am. J. Transplant. |
pmid:23730730
|
van Hooff JP et al. |
Glucose metabolic disorder after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17511670
|
Heffron TG et al. |
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17511684
|
Moench C et al. |
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17511685
|
Patlolla V et al. |
Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. |
2007 |
Am. J. Transplant. |
pmid:17564638
|
Min SI et al. |
Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy. |
2013 |
Am. J. Transplant. |
pmid:23734831
|
Tedesco-Silva H et al. |
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. |
2015 |
Am. J. Transplant. |
pmid:25988935
|
McDonald RA et al. |
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. |
2008 |
Am. J. Transplant. |
pmid:18416737
|
Triñanes J et al. |
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells. |
2017 |
Am. J. Transplant. |
pmid:28432716
|
Vanhove T et al. |
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients. |
2016 |
Am. J. Transplant. |
pmid:27013142
|
Posselt AM et al. |
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. |
2010 |
Am. J. Transplant. |
pmid:20659093
|
Pradhan M et al. |
Decline in renal function following thoracic organ transplantation in children. |
2002 |
Am. J. Transplant. |
pmid:12201367
|
Teuteberg JJ et al. |
Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes. |
2010 |
Am. J. Transplant. |
pmid:19889126
|
Jacobson PA et al. |
Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs. |
2012 |
Am. J. Transplant. |
pmid:22947444
|
Shapiro R et al. |
Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation. |
2007 |
Am. J. Transplant. |
pmid:17908272
|
De Simone P et al. |
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. |
2012 |
Am. J. Transplant. |
pmid:22882750
|
Echeverri GJ et al. |
Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. |
2009 |
Am. J. Transplant. |
pmid:19775318
|
Gaston RS et al. |
Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. |
2009 |
Am. J. Transplant. |
pmid:19459794
|
Rush D et al. |
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. |
2007 |
Am. J. Transplant. |
pmid:17908280
|
Turgut F and Akcay A |
Renal function estimation in cirrhosis. |
2009 |
Am. J. Transplant. |
pmid:19519814
|
Irish WD et al. |
Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database. |
2011 |
Am. J. Transplant. |
pmid:21564522
|
Tricot L et al. |
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. |
2009 |
Am. J. Transplant. |
pmid:19519819
|
Friman S et al. |
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21564523
|
Kofler S et al. |
Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective case-controlled study. |
2009 |
Am. J. Transplant. |
pmid:19519820
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|
Margreiter R et al. |
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. |
2008 |
Am. J. Transplant. |
pmid:18510632
|
Brennan DC et al. |
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. |
2005 |
Am. J. Transplant. |
pmid:15707414
|
Rogers J et al. |
Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation. |
2003 |
Am. J. Transplant. |
pmid:14510702
|